Skip to content

Pharma R&D · CDMO · Clinical Services

Science-led R&D.
Dependable CDMO scale-up.

A trusted partner for oral dosage forms and injectables — from concept through regulatory filing and commercial supply. Built on rigorous science, disciplined GMP, and a dedicated oncology capability.

17,600
Sq. Ft. facility
2
Dedicated labs
5+
Regulated markets
QbD
Driven development

Why Avidia

One partner. Reduced complexity.

QbD-Driven Development

Quality-by-Design ensures time-efficient, hassle-free regulatory submissions with robust CMC packages.

Cost Efficiency

Small-scale batch capability minimises API and raw material costs without compromising quality or compliance.

Rapid Response

Quick turnaround through an effective PM team — urgent batches handled with speed and precision.

Integrated CRO + CDMO

End-to-end capability from early research through commercial manufacturing — one partner, reduced complexity.

Dedicated Oncology Lab

A separate, segregated facility dedicated exclusively to anti-neoplastic formulations.

Global Regulatory Expertise

Deep US FDA & EU EMA experience with robust CMC, pharmacovigilance and regulatory submission support.

Get in touch

Let's build something dependable together.

Whether it's an early-stage formulation challenge, a 505(b)(2) program, or a commercial tech transfer — we'd be glad to talk through how we can help.